View Older Stories View More Recent Stories

Nov 10, 2025 08:07AM Foresight Expands Global Reach Through Strategic Collaboration with Leading Chinese Stereo Solutions Manufacturer
Nov 10, 2025 08:05AM Guardant Health expands blood test for late-stage cancer monitoring
Nov 10, 2025 08:05AM Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring
Nov 10, 2025 08:03AM Disguise expands Demon Slayer costume licensing deal with Aniplex
Nov 10, 2025 08:01AM Mainz Biomed to Attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS)
Nov 10, 2025 08:00AM Inspired by the Game, Engineered for Reality - Kojima Productions and Dnsys Launch the Dnsys Z1 Exoskeleton Pro - DEATH STRANDING 2: ON THE BEACH Limited Edition
Nov 10, 2025 08:00AM ESGold Completes Montauban Mill Building Construction and Moves Toward Production Readiness
Nov 10, 2025 08:00AM Rubrik to Report Third Quarter Fiscal 2026 Financial Results on December 4, 2025
Nov 10, 2025 08:00AM TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Uterine Fibroids on November 12, 2025
Nov 10, 2025 08:00AM Schneider Electric Launches Veteran Hiring Initiative to Build Mission-Ready Workforce for Critical Facilities
Nov 10, 2025 08:00AM Disguise and Aniplex Announce Expanded Licensing Agreement for Demon Slayer: Kimetsu no Yaiba Costumes and Accessories
Nov 10, 2025 08:00AM Mophie Announces New Juice Pack Battery Cases for iPhone Air, iPhone 17 Pro, and iPhone 17 Pro Max
Nov 10, 2025 08:00AM Brainomix Recognized in Global Health Tech Competition for Its Innovative Brainomix 360 Stroke Technology
Nov 10, 2025 08:00AM Millennial Potash Applauds the Official Addition of Potash to the 2025 List of Critical Minerals as Financial Times Mentions U.S. DFC Commitment to Millennial's Banio Potash Project in Gabon
Nov 10, 2025 07:45AM Revvity to acquire ACD/Labs to expand software capabilities
Nov 10, 2025 07:45AM Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities
Nov 10, 2025 07:30AM Ionis reports olezarsen cut triglyceride levels up to 72% in pivotal trials
Nov 10, 2025 07:30AM ESGold Completes Montauban Mill Building Construction and Moves Toward Production Readiness
Nov 10, 2025 07:02AM West Point Gold names Derek Macpherson CEO, adds Andrew Bowering to board
Nov 10, 2025 07:00AM Cogent Biosciences reports positive phase 3 trial results for GIST treatment
Nov 10, 2025 07:00AM Bitdeer reaches 41.2 EH/s hashrate, surpasses 40 EH/s target
Nov 10, 2025 07:00AM Bitdeer Reports Unaudited Financial Results for the Third Quarter of 2025
Nov 10, 2025 07:00AM MAX Power Brings Together Leading Natural Hydrogen Experts for Technical Collaboration and Drill Site Visit
Nov 10, 2025 07:00AM Bitdeer Announces October 2025 Production and Operations Update
Nov 10, 2025 07:00AM West Point Gold Announces Management and Board Changes; Appoints Andrew Bowering as Director
Nov 10, 2025 07:00AM Cogent Biosciences Reports Positive Results from Bezuclastinib PEAK Phase 3 Trial in Gastrointestinal Stromal Tumors (GIST)
Nov 10, 2025 06:30AM UPDF Web AI Launches Advanced PDF Conversion to Empower Users Worldwide
Nov 10, 2025 05:48AM LBank Exchange Listed ZardZardZard (ZARD)
Nov 10, 2025 05:30AM Record Vendor Turnout Powers High-Speed Fiber Device Compatibility
Nov 10, 2025 05:20AM Hometown Hero Donates $50,000 to Support Texas VFW Recruitment Efforts
Nov 10, 2025 05:19AM Ekox Launches Testnet v2 After Attracting 130K+ Users and $3B+ TVL
Nov 10, 2025 05:00AM UPDF 2025 Seasonal Promotion -- Empowering Users Worldwide to Work Smarter
Nov 10, 2025 04:00AM AESARA Announces Appointment of Jennifer Cain Birkmose as Vice President, Strategic Partnerships, Europe
Nov 10, 2025 04:00AM AHF’s Mobile Billboard Calls Out Gilead’s Greed at Pharma Summit
Nov 10, 2025 02:33AM BridgeBio's acoramidis shows mortality benefit in ATTR-CM variant patients
Nov 10, 2025 02:32AM Bitget Appoints Ignacio Aguirre Franco as Chief Marketing Officer to Drive Global Growth and UEX Evolution
Nov 10, 2025 01:00AM ECW Announces US$3.5 Million First Emergency Response Grant in Bangladesh
Nov 10, 2025 12:46AM Rumble Reports Third Quarter 2025 Results
Nov 9, 2025 05:00PM Merck's experimental oral cholesterol drug shows promise in genetic disorder trial
Nov 9, 2025 05:00PM Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Adults with Heterozygous Familial Hypercholesterolemia (HeFH) in Phase 3 CORALreef HeFH Trial
Nov 9, 2025 03:00PM United Network Redefines Self-Custody with a Next Gen Cold Wallet
Nov 9, 2025 06:31AM MoonBull Tops the List of Best Crypto Presales in 2025
Nov 9, 2025 04:07AM Bitcoin and Polygon Hold Steady as BullZilla Dominates the Best Crypto Presales in 2025
Nov 8, 2025 04:57PM Alnylam reports heart function improvements with vutrisiran in ATTR-CM study
Nov 8, 2025 04:57PM New Post Hoc Analysis from the HELIOS-B Phase 3 Study Shows Vutrisiran Improved Measures of Heart Structure and Function in Patients with ATTR-CM
Nov 8, 2025 02:30PM Merck's oral PCSK9 inhibitor shows 55.8% cholesterol reduction
Nov 8, 2025 02:30PM Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial
Nov 8, 2025 11:40AM New to The Street to Broadcast Show Number 698 on Bloomberg - Saturday, November 8, 2025, at 6:30 PM EST
Nov 8, 2025 10:41AM Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations
Nov 8, 2025 09:40AM Groundbreaking pivotal study results of olezarsen for severe hypertriglyceridemia (sHTG) presented as a late breaker at AHA Scientific Sessions
View More Recent Stories View Older Stories